Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    Immunotherapy with hLL1-DOX
Show Display Options
Rank Status Study
1 Active, not recruiting Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Drug: hLL1-DOX (IMMU-115)

Study has passed its completion date and status has not been verified in more than two years.